Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 7/12/2025​​​​​​​Recent Official and Executive Moves
  • 7/12/2025China's First 9-Valent HPV Vaccine Launches at 60% Discount, Undercutt...
  • 7/12/2025Flamma Opens New cGMP Plant in Dalian
  • 7/11/2025Vice Premier Urges Stronger Focus on Basic Pharmaceutical Research an...
  • 7/11/2025Evopoint's CLDN18.2‑Targeting ADC XNW27011 Launches First Phase III T...
  • 7/11/2025Regenelead's KRAS-Targeted Cancer Vaccine Approved for Clinical Trials...
  • 7/11/2025Biocytogen Strengthens Ties with BeOne Thru Expanded Antibody Licensin...
  • 7/11/2025TandemAI and Perpetual Medicine Announce Strategic Merger
  • 7/11/2025Haleon Secures Full Ownership of Tianjin Sino‑American JV
  • 7/11/2025BeOne's Tevimbra Wins EU Green Light for First-Line Nasopharyngeal Can...
  • 7/11/2025China's NHSA Unveils 2025 Drug Directory Revisions and Submission Guid...
  • 7/11/2025China Issues 2nd Batch of Rare Disease Clinical Guidelines to Strength...
  • 7/10/2025Henlius Wins Global Regulatory Clearance to Launch Phase 2 Trial of PD...
  • 7/10/2025China Approves Three New Drugs for Cancer, ED and Pediatric Sleep Diso...
  • 7/10/2025Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery...
  • 7/10/2025China's Biopharma Licensing Deals Surge in H1 2025, Fueled by Cross-Bo...
  • 7/9/2025Simcere Advances Rademikibart with NDA Submission for Atopic Dermatiti...
  • 7/9/2025China Struggles to Maintain Grip on India's Bulk Drug Market Amid Risi...
  • 7/9/2025Hansoh Pharma Launches Phase 1 Trial of HS-20093 with Adebrelimab in F...
  • 7/9/2025NKCellTech Secures Nearly CNY100M in Series A+++ Financing
  • 7/9/2025Adagene and ConjugateBio Launch a Strategic Partnership to Advance Bis...
  • 7/8/2025ArkBio's ADHD Drug Azstarys Granted Priority Review in China
  • 7/8/2025U.S. Lawmakers Raise Fresh Alarm Over GenScript's China Links
  • 7/8/2025Novo Nordisk Commits CNY 800M to Expand Quality Lab at Tianjin Manufac...
  • 7/8/2025NMPA Releases 93rd Batch of Reference Formulations for Generic Drug Ev...
  • 7/8/2025China's NMPA Reopens Public Consultation on Revised Conditional Approv...
  • 7/8/2025XellSmart Completes New Financing, Secures FDA Clearance for iPSC-Deri...
  • 7/8/2025DualityBio Launches Phase 3 Trial of HER2 ADC DB‑1303 in China for Re...
  • 7/8/2025Hansoh Launches Phase 1 Combo Trial of HS‑20093 ADC in ES‑SCLC
  • 7/8/2025Fosun USA and MAP International Partner to Expand Medicine Access
  • Page:1/53 Total number of articles:1589: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group